DeRemer DL - Search Results

1

Investigational drugs targeting FLT3 for leukemia.

Ustun C, DeRemer DL, Jillella AP, Bhalla KN. Ustun C, et al. Among authors: deremer dl. Expert Opin Investig Drugs. 2009 Oct;18(10):1445-56. doi: 10.1517/13543780903179278. Expert Opin Investig Drugs. 2009. PMID: 19671038 Review.

2

Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.

Ustun C, Farrow S, DeRemer D, Fain H, Jillella AP. Ustun C, et al. Bone Marrow Transplant. 2007 Jun;39(12):807-8. doi: 10.1038/sj.bmt.1705679. Epub 2007 Apr 16. Bone Marrow Transplant. 2007. PMID: 17438583 No abstract available.

3

Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem cell transplantation.

Ustun C, DeRemer DL, Steele JC Jr, Forseen C, Fisher JF, Jillella AP. Ustun C, et al. Among authors: deremer dl. Int J Antimicrob Agents. 2008 Oct;32(4):365-6. doi: 10.1016/j.ijantimicag.2008.04.014. Epub 2008 Jun 24. Int J Antimicrob Agents. 2008. PMID: 18572390 No abstract available.

4

Decitabine as "bridge therapy" to a MUD transplant in relapsed AML postautologous stem cell transplantation.

Ustun C, Kalla A, Farrow S, DeRemer DL, Jillella A. Ustun C, et al. Among authors: deremer dl. Am J Hematol. 2008 Oct;83(10):825-7. doi: 10.1002/ajh.21267. Am J Hematol. 2008. PMID: 18767131 Free article. No abstract available.

5

Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia.

Deremer DL, Ustun C, Natarajan K. Deremer DL, et al. Clin Ther. 2008 Nov;30(11):1956-75. doi: 10.1016/j.clinthera.2008.11.014. Clin Ther. 2008. PMID: 19108785 Review.

6

Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD.

Ustun C, Jillella A, Shah R, Sterling K, Deremer D, Savage N, Awan F, Gossage JR, Dillard T, Martin PJ. Ustun C, et al. Bone Marrow Transplant. 2010 Nov;45(11):1658-60. doi: 10.1038/bmt.2010.17. Epub 2010 Feb 22. Bone Marrow Transplant. 2010. PMID: 20173790 No abstract available.

7

Acute myelogenous leukemia patients are at low risk for invasive fungal infections after high-dose cytarabine consolidations and thus do not require prophylaxis.

Lewis G, Hall P, Eisa N, Deremer D, Dobbins R, El-Geneidy M, Jillella A, Ustun C. Lewis G, et al. Acta Haematol. 2010;124(4):206-13. doi: 10.1159/000321504. Epub 2010 Nov 12. Acta Haematol. 2010. PMID: 21071929

8

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia.

Deremer DL, Katsanevas K, Ustun C. Deremer DL, et al. Cancer Manag Res. 2011 Mar 10;3:65-78. doi: 10.2147/CMR.S11948. Cancer Manag Res. 2011. PMID: 21556318 Free PMC article.

9

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis.

Ustun C, DeRemer DL, Akin C. Ustun C, et al. Among authors: deremer dl. Leuk Res. 2011 Sep;35(9):1143-52. doi: 10.1016/j.leukres.2011.05.006. Epub 2011 Jun 8. Leuk Res. 2011. PMID: 21641642 Review.

10

Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies.

Hamadani M, Kochuparambil ST, Osman S, Cumpston A, Leadmon S, Bunner P, Watkins K, Morrison D, Speir E, Deremer D, Kota V, Jillella A, Craig M, Awan F. Hamadani M, et al. Biol Blood Marrow Transplant. 2012 Jul;18(7):1128-35. doi: 10.1016/j.bbmt.2012.01.005. Epub 2012 Jan 14. Biol Blood Marrow Transplant. 2012. PMID: 22248715 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters